MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Mitochondrial leukoencephalopathies: A border zone between acquired and inherited white matter disorders in children?
|
29353736 |
2018 |
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Mitochondrial leukoencephalopathies: A border zone between acquired and inherited white matter disorders in children?
|
29353736 |
2018 |
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
LYRM7 - associated complex III deficiency: A clinical, molecular genetic, MR tomographic, and biochemical study.
|
28694194 |
2017 |
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Severe respiratory complex III defect prevents liver adaptation to prolonged fasting.
|
27151179 |
2016 |
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
LYRM7 mutations cause a multifocal cavitating leukoencephalopathy with distinct MRI appearance.
|
26912632 |
2016 |
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Update on Leukodystrophies: A Historical Perspective and Adapted Definition.
|
27564080 |
2016 |
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8
|
0.600 |
GeneticVariation
|
disease |
UNIPROT |
A homozygous mutation in LYRM7/MZM1L associated with early onset encephalopathy, lactic acidosis, and severe reduction of mitochondrial complex III activity.
|
24014394 |
2013 |
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8
|
0.600 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
MITOCHONDRIAL COMPLEX III DEFICIENCY (disorder)
|
0.300 |
Biomarker
|
disease |
CTD_human |
|
|
|
Encephalopathies
|
0.120 |
GeneticVariation
|
group |
BEFREE |
Mutations in LYRM7 were previously found in a single patient with a severe form of infantile onset encephalopathy.
|
26912632 |
2016 |
Encephalopathies
|
0.120 |
GeneticVariation
|
group |
BEFREE |
A homozygous mutation in LYRM7/MZM1L associated with early onset encephalopathy, lactic acidosis, and severe reduction of mitochondrial complex III activity.
|
24014394 |
2013 |
Encephalopathies
|
0.120 |
Biomarker
|
group |
HPO |
|
|
|
Acidosis, Lactic
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Anemia
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Ataxia
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Dysarthria
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Exotropia
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Failure to Thrive
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Lethargy
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Nystagmus
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Muscle Weakness
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
External Ophthalmoplegia
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Cerebral atrophy
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Hypoplasia of corpus callosum
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|